Literature DB >> 32632336

RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells.

Yicheng Long1,2, Taeyoung Hwang1, Anne R Gooding1,2, Karen J Goodrich1,2, John L Rinn3,4, Thomas R Cech5,6.   

Abstract

Many chromatin-binding proteins and protein complexes that regulate transcription also bind RNA. One of these, Polycomb repressive complex 2 (PRC2), deposits the H3K27me3 mark of facultative heterochromatin and is required for stem cell differentiation. PRC2 binds RNAs broadly in vivo and in vitro. Yet, the biological importance of this RNA binding remains unsettled. Here, we tackle this question in human induced pluripotent stem cells by using multiple complementary approaches. Perturbation of RNA-PRC2 interaction by RNase A, by a chemical inhibitor of transcription or by an RNA-binding-defective mutant all disrupted PRC2 chromatin occupancy and localization genome wide. The physiological relevance of PRC2-RNA interactions is further underscored by a cardiomyocyte differentiation defect upon genetic disruption. We conclude that PRC2 requires RNA binding for chromatin localization in human pluripotent stem cells and in turn for defining cellular state.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32632336     DOI: 10.1038/s41588-020-0662-x

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  62 in total

1.  Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Authors:  Ru Cao; Liangjun Wang; Hengbin Wang; Li Xia; Hediye Erdjument-Bromage; Paul Tempst; Richard S Jones; Yi Zhang
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

Review 2.  Biochemical mechanisms of gene regulation by polycomb group protein complexes.

Authors:  Jürg Müller; Peter Verrijzer
Journal:  Curr Opin Genet Dev       Date:  2009-04-01       Impact factor: 5.578

Review 3.  Chromatin proteins and modifications as drug targets.

Authors:  Kristian Helin; Dashyant Dhanak
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

Review 4.  Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice.

Authors:  Bernd Schuettengruber; Giacomo Cavalli
Journal:  Development       Date:  2009-11       Impact factor: 6.868

Review 5.  The structure, function and evolution of proteins that bind DNA and RNA.

Authors:  William H Hudson; Eric A Ortlund
Journal:  Nat Rev Mol Cell Biol       Date:  2014-10-01       Impact factor: 94.444

6.  The polycomb group protein Suz12 is required for embryonic stem cell differentiation.

Authors:  Diego Pasini; Adrian P Bracken; Jacob B Hansen; Manuela Capillo; Kristian Helin
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

Review 7.  Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation.

Authors:  Anne Laugesen; Jonas Westergaard Højfeldt; Kristian Helin
Journal:  Mol Cell       Date:  2019-04-04       Impact factor: 17.970

8.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.

Authors:  Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

Review 9.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

Review 10.  How do lncRNAs regulate transcription?

Authors:  Yicheng Long; Xueyin Wang; Daniel T Youmans; Thomas R Cech
Journal:  Sci Adv       Date:  2017-09-27       Impact factor: 14.136

View more
  40 in total

1.  Competition between PRC2.1 and 2.2 subcomplexes regulates PRC2 chromatin occupancy in human stem cells.

Authors:  Daniel T Youmans; Anne R Gooding; Robin D Dowell; Thomas R Cech
Journal:  Mol Cell       Date:  2020-12-17       Impact factor: 17.970

Review 2.  Non-coding RNAs in chromatin folding and nuclear organization.

Authors:  Sergey V Razin; Alexey A Gavrilov
Journal:  Cell Mol Life Sci       Date:  2021-06-11       Impact factor: 9.261

Review 3.  Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction.

Authors:  Yiran Guo; Shuai Zhao; Gang Greg Wang
Journal:  Trends Genet       Date:  2021-01-22       Impact factor: 11.639

Review 4.  Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis.

Authors:  Yi Qiu; Mingjiang Xu; Suming Huang
Journal:  Blood       Date:  2021-12-09       Impact factor: 22.113

Review 5.  The control of polycomb repressive complexes by long noncoding RNAs.

Authors:  Jackson B Trotman; Keean C A Braceros; Rachel E Cherney; McKenzie M Murvin; J Mauro Calabrese
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-04-16       Impact factor: 9.957

Review 6.  Long noncoding RNAs in cancer metastasis.

Authors:  S John Liu; Ha X Dang; Daniel A Lim; Felix Y Feng; Christopher A Maher
Journal:  Nat Rev Cancer       Date:  2021-05-05       Impact factor: 60.716

Review 7.  RNA matchmaking in chromatin regulation.

Authors:  Stephen K Wu; Justin T Roberts; Maggie M Balas; Aaron M Johnson
Journal:  Biochem Soc Trans       Date:  2020-12-18       Impact factor: 5.407

Review 8.  Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy.

Authors:  Tianshu Yang; Yunkai Yang; Yan Wang
Journal:  Clin Epigenetics       Date:  2021-05-17       Impact factor: 6.551

9.  Cis-acting lnc-Cxcl2 restrains neutrophil-mediated lung inflammation by inhibiting epithelial cell CXCL2 expression in virus infection.

Authors:  Shuo Liu; Jiaqi Liu; Xue Yang; Minghong Jiang; Qingqing Wang; Lianfeng Zhang; Yuanwu Ma; Zhongyang Shen; Zhigang Tian; Xuetao Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-12       Impact factor: 11.205

Review 10.  Decoding LncRNAs.

Authors:  Lidia Borkiewicz; Joanna Kalafut; Karolina Dudziak; Alicja Przybyszewska-Podstawka; Ilona Telejko
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.